FDA cleared the VIRTUE QA from ProNova Solutions on Sep 23, 2026 under K260597, a traditional 510(k). The device falls under product code LHN, System, Radiation Therapy, Charged-Particle, Medical, regulated at 21 CFR 892.5050 as a Class 2 device. The review panel was Radiology.
FDA logged the submission as received on Feb 24, 2026. The decision came 211 days later, longer than the 90 FDA-day review goal, which usually means at least one additional information request.
This is the only decision on file for ProNova Solutions in the last 12 months of the tracker.